Literature DB >> 12021155

Cardiovascular function in patients with insulin-dependent diabetes mellitus: a study using noninvasive methods.

S K Rajan1, Shefali M Gokhale.   

Abstract

This study used noninvasive methods to assess disturbance in cardiovascular function in insulin-dependent diabetes mellitus (IDDM) patients. Cardiovascular function and the autonomic nervous system of 38 IDDM patients were assessed, and the presence or absence of left ventricular dysfunction was determined. Fifty-six percent of the patients were found to have autonomic neuropathy. Twelve percent had left ventricular diastolic dysfunction; none had left ventricular systolic dysfunction. Heart disease in IDDM patients was found to constitute a separate entity, termed diabetic cardiomyopathy. All IDDM patients with left ventricular diastolic dysfunction had evidence of autonomic neuropathy. However, there was no correlation with left ventricular systolic dysfunction. Also, there was no correlation between left ventricular dysfunction and microvascular complications of diabetes mellitus.

Entities:  

Mesh:

Year:  2002        PMID: 12021155     DOI: 10.1111/j.1749-6632.2002.tb03018.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria.

Authors:  Merih Baykan; Turan Erdogan; Cihangir Erem; Arif Hacihasanoglu; Omer Gedikli; Mehmet Küçükosmanoglu; Sukru Celik; Cihan Orem
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.633

Review 3.  Metabolic, structural and biochemical changes in diabetes and the development of heart failure.

Authors:  Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

Review 4.  Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist.

Authors:  Efstratios E Apostolakis; Nikolaos G Baikoussis; Haralabos Parissis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2009-11-24       Impact factor: 1.637

5.  Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM).

Authors:  A Vazeou; A Papadopoulou; M Miha; A Drakatos; D Georgacopoulos
Journal:  Eur J Pediatr       Date:  2007-10-27       Impact factor: 3.183

6.  Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.

Authors:  Lydia M Le Page; Oliver J Rider; Andrew J Lewis; Vicky Ball; Kieran Clarke; Edvin Johansson; Carolyn A Carr; Lisa C Heather; Damian J Tyler
Journal:  Diabetes       Date:  2015-03-20       Impact factor: 9.461

7.  Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.

Authors:  Kenichi Watanabe; Rajarajan A Thandavarayan; Meilei Harima; Flori R Sari; Narasimman Gurusamy; Punniyakoti T Veeraveedu; Sayaka Mito; Wawaimuli Arozal; Vijayakumar Sukumaran; Arun Prasath Laksmanan; Vivian Soetikno; Makoto Kodama; Yoshifusa Aizawa
Journal:  Curr Cardiol Rev       Date:  2010-11

8.  Nigella sativa: A potential natural protective agent against cardiac dysfunction in patients with type 2 diabetes mellitus.

Authors:  Abdullah Bamosa; Huda Kaatabi; Ahmed Badar; Akram Al-Khadra; Abdulmohsen Al Elq; Bodour Abou-Hozaifa; Fatma Lebda; Sameeh Al-Almaie
Journal:  J Family Community Med       Date:  2015 May-Aug

Review 9.  The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.

Authors:  Qutuba G Karwi; Qiuyu Sun; Gary D Lopaschuk
Journal:  Cells       Date:  2021-11-21       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.